Research Article

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma

Table 2

22 key molecules identified by LASSO-Cox regression.

MoleculesAnnotationCoefficient

ACVR1 (Activin A Receptor Type 1)Mutation−0.31351085
ARID1A (AT-Rich Interaction Domain 1A)Mutation−0.230538257
ATM (Ataxia Telangiectasia Mutated)Mutation−0.095420173
BIRC6 (Baculoviral IAP Repeat Containing 6)Mutation−0.13931703
ERBB3 (Erb-B2 Receptor Tyrosine Kinase 3)Mutation−0.167684278
HOXA11 (Homeobox A11)Mutation0.340669897
POLE (DNA Polymerase Epsilon)Mutation−0.18491545
POLQ (DNA Polymerase Theta)Mutation−0.035077258
SPOP (Speckle Type BTB/POZ Protein)Mutation−0.094758819
GINS4 (SLD5,GINS Complex Subunit 4)CNV0.058592508
GORAB (Golgin, RAB6 Interacting)CNV0.074299734
GSTM1 (Glutathione S-Transferase Mu 1)CNV0.172758754
KCNMB3 (Potassium Calcium-Activated Channel Subfamily M Regulatory Beta Subunit 3)CNV−0.111711137
PTPN22 (Protein Tyrosine Phosphatase Non-Receptor Type 22)DEG−0.074886487
CDH18 (Cadherin 18)DEG0.197447688
KCNK3 (Potassium Two Pore Domain Channel Subfamily K Member 3)DEG0.047114247
PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1)DEG0.114882922
KCNJ12 (Potassium Inwardly Rectifying Channel Subfamily J Member 12)DEG0.131411471
NCMAP (Non-Compact Myelin Associated Protein)DEG−0.024703756
cg07792478CpG of IR124-20.327359364
cg13703871CpG of NF1770.583394392
cg14398860CpG of INPP5A0.133967149

(CNV, copy number variance; DEG, differentially expressed genes)